Press Releases

BOSTON, March 5, 2020 /PRNewswire/ -- Aspera, the leading global provider of solutions and services for Software Asset Management 

NEW PROVIDENCE, N.J., March 5, 2020 /PRNewswire/ -- The COVID-19 coronavirus that's spreading around the world has made it clear that all employers need to have a written Contagious Disease P

SILVER SPRING, Md., March 5, 2020 /PRNewswire/ -- The American College Health Association (ACHA) announces the release of its new guidelines, Preparing for COVID-19. Prepared by the ACHA COVID-19 Task Force, these guidelines are designed to help college health and well-being health professionals and campus administrators prepare for coronavirus disease 2019 (COVI

BALTIMORE, March 5, 2020 /PRNewswire/ -- HemaTerra Technologies acquired Champion Healthcare Technologies in 2019 and is now rebranding the new entity as InVita Healthcare Technologies. The InVita brand combines industry-leading solutions for optimizing the supply chain performance of blood, plasma, tissue, implants, and others. More than 600 customers—blood cente

DALLAS, March 5, 2020 /PRNewswire/ -- Consumers expect the same level of digital capability and self enablement from their healthcare providers that they have become accustomed to in other industries; and, at the core of that expectation is the healthcare consumer's desire for the convenience of anytime, anywhere mobile access to their personal health information and pr

LAUSANNE, Switzerland, March 5, 2020 /PRNewswire/ -- Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today the advancement

CHICAGO, March 5, 2020 /PRNewswire/ -- ImmersiveTouch has announced a collaboration with HP that strives to unleash the power of personalized medicine by providing the missing link between medical imaging and real-time surgery. This collaboration will pair ImmersiveTouch clinical software with HP hardware to create better healthcare outcomes at reduced costs. The compan

VANCOUVER, March 5, 2020 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), plans to release its results for the quarter and year ended December 31, 2019, on Wednesday, March 11, 2020 after market close. The Company's executive management will discuss the resu

SOUTH SAN FRANCISCO, Calif., March 5, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced the presentation of new data demonstrating that using Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo] to treat patients with intracranial hemorrhage (ICH) associated with the oral Factor Xa inhibitor

GREENVILLE, N.C., March 5, 2020 /PRNewswire/ -- Eastern Nephrology Associates (ENA) has announced its participation and investment in a new entity aimed at improving healthcare outcomes for Americans living with kidney disease. This new population health management company,